Get the Stockscreener App
2.41
0.82%
-0.02
After Hours:
2.40
-0.01
-0.41%
Oramed Pharmaceuticals Inc stock is traded at $2.41, with a volume of 102.56K.
It is down -0.82% in the last 24 hours and up +14.76% over the past month.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
See More
Previous Close:
$2.43
Open:
$2.3765
24h Volume:
102.56K
Relative Volume:
1.42
Market Cap:
$98.82M
Revenue:
$2.70M
Net Income/Loss:
$5.53M
P/E Ratio:
21.91
EPS:
0.11
Net Cash Flow:
$-10.55M
1W Performance:
+8.07%
1M Performance:
+14.76%
6M Performance:
-2.43%
1Y Performance:
+2.12%
1-Day Range:
$2.3697
$2.43
1-Week Range:
$2.23
$2.45
52-Week Range:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Name
Oramed Pharmaceuticals Inc
Sector
Industry
Phone
646-844-1164
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Compare ORMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.41 | 95.54M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-20-21 | Initiated | Canaccord Genuity | Buy |
| Feb-09-21 | Initiated | National Securities | Buy |
| Dec-03-20 | Initiated | Alliance Global Partners | Buy |
| Mar-11-20 | Initiated | Aegis Capital | Buy |
| Sep-11-19 | Initiated | Ladenburg Thalmann | Buy |
| Dec-11-17 | Resumed | B. Riley FBR, Inc. | Buy |
| May-26-16 | Reiterated | FBR Capital | Outperform |
| Dec-01-15 | Reiterated | H.C. Wainwright | Buy |
| Nov-19-15 | Initiated | FBR Capital | Outperform |
| Apr-13-15 | Resumed | MLV & Co | Buy |
| Jan-30-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Reiterated | Aegis Capital | Buy |
| Jan-08-14 | Initiated | MLV & Co | Buy |
| Dec-03-13 | Initiated | Aegis Capital | Buy |
View All
Oramed Pharmaceuticals Inc Stock (ORMP) Latest News
How to recover losses in Oramed Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - Newser
How moving averages guide Oramed Pharmaceuticals Inc. tradingJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Chart based exit strategy for Oramed Pharmaceuticals Inc.Portfolio Value Summary & Accurate Buy Signal Alerts - Newser
Is Oramed Pharmaceuticals Inc. forming a bottoming baseWeekly Stock Summary & Smart Swing Trading Techniques - Newser
How to integrate Oramed Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Oramed Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Will Oramed Pharmaceuticals Inc. continue its uptrendEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Advanced analytics toolkit walkthrough for Oramed Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
Should you hold or exit Oramed Pharmaceuticals Inc. nowBear Alert & Accurate Buy Signal Notifications - Newser
Earnings visualization tools for Oramed Pharmaceuticals Inc.Analyst Downgrade & Daily Price Action Insights - Newser
Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - Newser
Is Oramed Pharmaceuticals Inc. still worth holding after the dip2025 Risk Factors & AI Powered Market Entry Strategies - Newser
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Can Oramed Pharmaceuticals Inc. recover in the next quarterJuly 2025 Short Interest & Long-Term Growth Plans - Newser
What MACD and RSI say about Oramed Pharmaceuticals Inc.2025 Institutional Moves & Short-Term Trading Alerts - Newser
What indicators show strength in Oramed Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - Newser
Evaluating Oramed Pharmaceuticals Inc. with trendline analysis2025 Big Picture & Safe Entry Momentum Tips - Newser
Detecting price anomalies in Oramed Pharmaceuticals Inc. with AIPortfolio Profit Report & Real-Time Buy Zone Alerts - Newser
What makes Oramed Pharmaceuticals Inc. stock price move sharplyMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Identifying reversal signals in Oramed Pharmaceuticals Inc.Treasury Yields & Safe Capital Growth Tips - Newser
Can volume confirm reversal in Oramed Pharmaceuticals Inc.Inflation Watch & Consistent Return Investment Signals - Newser
Building trade automation scripts for Oramed Pharmaceuticals Inc.July 2025 WrapUp & Verified Chart Pattern Trade Signals - Newser
Published on: 2025-09-09 17:48:00 - Newser
Chart based analysis of Oramed Pharmaceuticals Inc. trendsJuly 2025 Breakouts & Safe Entry Point Identification - Newser
What drives Oramed Pharmaceuticals Inc.’s stock priceEarnings Performance Report & Weekly Top Gainers Trade List - Lancaster City Council
Is this a good reentry point in Oramed Pharmaceuticals Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - Newser
how to recover losses in oramed pharmaceuticals inc. stockPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - Newser
Oramed Pharmaceuticals Inc. stock retracement – recovery analysisMarket Trend Summary & AI Forecast Swing Trade Picks - Newser
will oramed pharmaceuticals inc. continue its uptrendEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Oramed Pharmaceuticals Inc. stock volume spike explainedTrade Signal Summary & Safe Entry Momentum Stock Tips - Newser
Will Oramed Pharmaceuticals Inc. rebound enough to break evenQuarterly Earnings Report & Expert Curated Trade Ideas - Newser
Does Oramed Pharmaceuticals Inc. fit your quant trading model2025 Earnings Impact & Real-Time Volume Analysis Alerts - Newser
Applying chart zones and confluence areas to Oramed Pharmaceuticals Inc.July 2025 Chart Watch & Verified Momentum Watchlists - Newser
Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):